Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study
Christoffer Gebhardt, Sonja C. S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland‐Letz, Viktor Umansky, Jochen Utikal
Topics & Concepts
PaclitaxelMelanomaCD8BlockadeMedicineImmunotherapyImmune systemPharmacologyImmunologyCancer researchDownregulation and upregulationImmune checkpointChemotherapyOncologyBiologyInternal medicineReceptorBiochemistryGeneImmune cells in cancerCancer Immunotherapy and BiomarkersImmune Response and Inflammation